tiprankstipranks
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market
2616
CStone Pharmaceuticals
RESEARCH TOOLSreports
Want to see HK:2616 full AI Analyst Report?

CStone Pharmaceuticals (2616) Revenue

4 Followers
StatisticsMarket CapRevenue

CStone Pharmaceuticals Revenue

CStone Pharmaceuticals had a revenue of 216.46M in the quarter ending Dec 31, 2025, with 775.45%. This bring the company's revenue in the last twelve months to 241.18M, Decreased 35.68%. In the fiscal year ending Dec 31, 2025, CStone Pharmaceuticals had annual revenue of 262.61M with -35.51% growth.
Revenue (ttm)
241.18M
Revenue Growth
-33.37%
P/S Ratio
56.17
Revenue/Employee
HK$1,945,229
Employees
135
Market Cap
HK$14.75B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
262.61M-144.60M-35.51%
Dec 31, 2024
407.20M-56.64M-12.21%
Dec 31, 2023
463.84M-17.52M-3.64%
Dec 31, 2022
481.36M237.65M+97.51%
Dec 31, 2021
243.72M-795.11M-76.54%
Dec 31, 2020
1.04B―+∞%
Dec 31, 2019
―-12.55M-100.00%
Dec 31, 2018
12.55M2.25M+21.84%
Dec 31, 2017
10.30M――